Senti Biosciences Holdings (SNTI) Return on Sales [ROS] (2021 - 2026)
Senti Biosciences Holdings (SNTI) reported Return on Sales [ROS] of -85229.41% for Q2 2026.
Powered by 
Analysis
Senti Biosciences Holdings (SNTI) Return on Sales [ROS] (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Senti Biosciences Holdings' Return on Sales [ROS] came in at -393358.82%; for FY2025, it came in at -312631.82%.
- Return on Sales [ROS] has a four-year change of -311166.91 percentage points (FY2021 to FY2025).
- By year, Return on Sales [ROS] came in at -3620.73% in FY2023 (-2172.20 pp), -1448.53% in FY2022 (+16.37 pp) and -1464.90% in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Return on Sales [ROS] in data going back to Q2 2021.
- The high point for year-over-year Return on Sales [ROS] in five years was Q4 2023 (a gain of 24843.71 percentage points); the low point was Q4 2022 (a drop of 27091.77 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Senti Biosciences Holdings | 9.97 Mn | 9.97 Mn | - | -85,229.41% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -85,229.41% |
| Jun 30, 2024 | -27,287.28% |
| Mar 31, 2024 | -7,377.49% |
| Dec 31, 2023 | -3,620.70% |
| Sep 30, 2023 | -12,981.07% |
| Jun 30, 2023 | -1,620.92% |
| Mar 31, 2023 | -1,163.61% |
| Dec 31, 2022 | -28,464.41% |
| Sep 30, 2022 | -835.11% |
| Jun 30, 2022 | -1,603.17% |
| Mar 31, 2022 | -1,065.04% |
| Dec 31, 2021 | -1,372.64% |
| Sep 30, 2021 | -1,035.63% |
| Jun 30, 2021 | -1,134.43% |
API Access
Senti Biosciences Holdings Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SNTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "SNTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=SNTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();